Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of ...

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

Less than 10% of the millions eligible for the so-called "King Kong of weight loss drugs" will be able to get it in the next three years, according to guidance by the National Institute for Health ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...

A damning report from the Care Quality Commission (CQC) found that Doncaster-based Elements Medical was inadequate in every area it inspected.